The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down.
In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry.
This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time.
Precision (or personalized)
Read More
dna
Why Families Need the Closure Whole Genome Sequencing Provides
For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents of the patient, especially when searching for a diagnosis can go on for years. This is the essence of what is known as the “diagnostic odyssey.”
Honing in on a rare disease diagnosis involves thorough medical history evaluations,
Read More
Meaningful Use of Genomics Requires Informatics Beyond EMRs
Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care.
But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic and genomic information during clinical decision making, is a compelling example that functionality beyond the EMR is required. Not only does genomic data represent a
Read More
AMA Adds 3 Additional CPT Codes for AstraZeneca’s COVID-19 Vaccine
What You Should Know:
- The American Medical Association (AMA) announced the addition of three Current Procedural Terminology (CPT) codes for AstraZeneca's COVID-19 vaccine.
The American Medical Association (AMA) today announced that
the Current Procedural Terminology (CPT®) code set is
being updated by the CPT Editorial Panel to include immunization and
administration codes that are unique to the COVID-19 vaccine under development
by AstraZeneca and University of
Read More
AMA Adds New CPT Codes Multi-Virus Tests to Detect COVID-19 and Flu
What You Should Know:
- AMA
announces new CPT codes for multi-virus tests to detect COVID-19 and flu for
immediate use.
The American Medical Association (AMA) today published an update to the Current Procedural Terminology (CPT®) code set that includes new code additions and editorial revisions for reporting medical services sparked by the public health response to the COVID-19 pandemic. The update to the CPT code set was approved by the CPT Editorial Panel, the
Read More
Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration
What You Should Know:
- Nebula Genomics announces integration with Oasis Labs to give its customers full ownership and control of the data received from their comprehensive genome sequencing tests.
- Through Oasis Labs’ unique privacy solution Parcel, Nebula’s
users will be able to retain ownership and control of their personal genomic data.
Data remains confidential, and users can grant access to their data for
specific use cases such as generation of reports offered by Nebula or
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health
What You Should Know:
- DNA Company acquires AI-based digital therapeutics app My Pain Sensei (MPS) to form My Next Health and is building a COVID-19 risk assessment platform to help people understand their risks of developing serious COVID-19 complications.
- The acquisition combines functional genomics with conversational AI for patient self-management apps and disease tracking tools designed to inform clinician-patient interactions.
Leading functional genomics provider The
Read More
FDA Approves Emergency Use Authorization for a 24-hour, Saliva Test for COVID-19
What You Should Know:
- The FDA has provided Emergency Use Authorization for a 24-hour, Saliva Test for COVID-19, available now to clinics, hospitals, and patients.
- In light of recent complications with and warnings for new tests, here is a quick list of information on the validated test and how it is different from existing testing and other alternatives in development:
- The saliva-based test for COVID-19 has been validated and proven as a consistent sample method.
- FDA
Read More
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know:
- More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic.
- The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
